Literature DB >> 11433548

Towards more optimal medical diagnosing with evolutionary algorithms.

V Podgorelec1, P Kokol.   

Abstract

Efficiency in hospital performance is becoming more and more important. Studies showed that diagnosis can considerably reduce the inefficiency, so one of the most important tasks in achieving greater hospital efficiency is to optimize the diagnostic process. For the best of the patient the diagnostic process has to be optimized regarding the number of the examinations and individualized in order to maximize accuracy, sensitivity and specificity. In addition the duration of the diagnostic process has to be minimized and the process has to be performed on the most reliable equipment. The main contribution of our paper is the introduction of the integrated computerized environment DIAPRO enabling the diagnostic process optimization. The DIAPRO is based on a single approach--evolutionary algorithms.

Entities:  

Mesh:

Year:  2001        PMID: 11433548     DOI: 10.1023/a:1010733016906

Source DB:  PubMed          Journal:  J Med Syst        ISSN: 0148-5598            Impact factor:   4.460


  13 in total

1.  Estimating hospital inefficiency: does case mix matter?

Authors:  M D Rosko; J A Chilingerian
Journal:  J Med Syst       Date:  1999-02       Impact factor: 4.460

Review 2.  Artificial neural network as a novel method to optimize pharmaceutical formulations.

Authors:  K Takayama; M Fujikawa; T Nagai
Journal:  Pharm Res       Date:  1999-01       Impact factor: 4.200

3.  An adaptive control algorithm for optimization of intensity modulated radiotherapy considering uncertainties in beam profiles, patient set-up and internal organ motion.

Authors:  J Löf; B K Lind; A Brahme
Journal:  Phys Med Biol       Date:  1998-06       Impact factor: 3.609

4.  Experimental design for a pharmaceutical formulation: optimisation and robustness.

Authors:  B Campisi; D Chicco; D Vojnovic; R Phan-Tan-Luu
Journal:  J Pharm Biomed Anal       Date:  1998-10       Impact factor: 3.935

5.  Genetic algorithm based system for patient scheduling in highly constrained situations.

Authors:  V Podgorelec; P Kokol
Journal:  J Med Syst       Date:  1997-12       Impact factor: 4.460

6.  Decision theoretic steering and genetic algorithm optimization: application to stereotactic radiosurgery treatment planning.

Authors:  Y Yu; M C Schell; J B Zhang
Journal:  Med Phys       Date:  1997-11       Impact factor: 4.071

7.  An active set algorithm for treatment planning optimization.

Authors:  D H Hristov; B G Fallone
Journal:  Med Phys       Date:  1997-09       Impact factor: 4.071

8.  Diagnosis and prognosis of mitral-valve prolapse.

Authors:  R B Devereux
Journal:  N Engl J Med       Date:  1989-04-20       Impact factor: 91.245

9.  Mitral valve prolapse in one hundred presumably healthy young females.

Authors:  W Markiewicz; J Stoner; E London; S A Hunt; R L Popp
Journal:  Circulation       Date:  1976-03       Impact factor: 29.690

10.  Decision trees based on automatic learning and their use in cardiology.

Authors:  P Kokol; M Mernik; J Zavrsnik; K Kancler; I Malcić
Journal:  J Med Syst       Date:  1994-08       Impact factor: 4.460

View more
  4 in total

Review 1.  Decision trees: an overview and their use in medicine.

Authors:  Vili Podgorelec; Peter Kokol; Bruno Stiglic; Ivan Rozman
Journal:  J Med Syst       Date:  2002-10       Impact factor: 4.460

2.  Improving the reliability of medical software by predicting the dangerous software modules.

Authors:  Vili Podgorelec; Marjan Hericko; Matjaz B Juric; Ivan Rozman
Journal:  J Med Syst       Date:  2005-02       Impact factor: 4.460

3.  Improving the efficiency of physical examination services.

Authors:  Wheyming Tina Song; Mingchang Chih; Aaron E Bair
Journal:  J Med Syst       Date:  2009-04-28       Impact factor: 4.460

4.  An extensible six-step methodology to automatically generate fuzzy DSSs for diagnostic applications.

Authors:  Antonio d'Acierno; Massimo Esposito; Giuseppe De Pietro
Journal:  BMC Bioinformatics       Date:  2013-01-14       Impact factor: 3.169

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.